Patent application number | Description | Published |
20130171450 | CORDS MADE OF CELLULOSIC MULTIFILAMENT YARNS HAVING AN INCREASED LINEAR DENSITY OF INDIVIDUAL FILAMENTS - A cord, in particular for reinforcing tyres, containing a cellulosic multifilament yarn is disclosed, where the cellulosic multifilament yarn has a strength of at least 35 cN/tex and the individual filaments of the multifilament yarn have a linear density of at least 2.3 dtex. In use, such cords exhibit a significantly improved fatigue behaviour—i.e., a significantly higher fatigue resistance—than standard cords with an individual-filament linear density between 1 and 2 dtex. | 07-04-2013 |
20150322595 | HIGH-TENACITY VISCOSE MULTIFILAMENT YARN WITH LOW YARN LINEAR DENSITY - A viscose multifilament yarn has a crystallinity in the range from 15% to 40%, and, after conditioning in the standard climate according to DIN EN ISO 139-1:2005, a yarn linear density in the range from ≧150 dtex to <1100 dtex and a tensile strength in the range from ≧45 cN/tex to ≦55 cN/tex. | 11-12-2015 |
20160047069 | HYBRID CORD CONSISTING OF AT LEAST TWO MULTIFILAMENT YARNS TWISTED TOGETHER - A hybrid cord of at least two multifilament yarns twisted together is described, where the first yarn is a viscose multifilament yarn and the second yarn is a non-metallic multifilament yarn composed of a material that is not identical to the first multifilament yarn. The viscose multifilament yarn is conditioned in the standard climate in accordance with DIN EN ISO 139-1:2005, and has a yarn linear density <1100 dtex and a breaking tenacity of ≧45 cN/tex. The hybrid cord has a cord linear density of ≦3000 dtex. | 02-18-2016 |
Patent application number | Description | Published |
20120177195 | VOICE OVER DATA TELECOMMUNICATIONS NETWORK ARCHITECTURE - The present invention describes a system and method for communicating voice and data over a packet-switched network that is adapted to coexist and communicate with a legacy PSTN. The system permits packet switching of voice calls and data calls through a data network from and to any of a LEC, a customer facility or a direct IP connection on the data network. The system includes soft switch sites, gateway sites, a data network, a provisioning component, a network event component and a network management component. The system interfaces with customer facilities (e.g., a PBX), carrier facilities (e.g., a LEC) and legacy signaling networks (e.g., SS7) to handle calls between any combination of on-network and off-network callers. | 07-12-2012 |
20130070757 | VOICE OVER DATA TELECOMMUNICATIONS NETWORK ARCHITECTURE - The present invention describes a system and method for communicating voice and data over a packet-switched network that is adapted to coexist and communicate with a legacy PSTN. The system permits packet switching of voice calls and data calls through a data network from and to any of a LEC, a customer facility or a direct IP connection on the data network. The system includes soft switch sites, gateway sites, a data network, a provisioning component, a network event component and a network management component. The system interfaces with customer facilities (e.g., a PBX), carrier facilities (e.g., a LEC) and legacy signaling networks (e.g., SS7) to handle calls between any combination of on-network and off-network callers. | 03-21-2013 |
Patent application number | Description | Published |
20110008325 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid Prepared from a Unit Dose Suspension - An inhalable unit dose liquid formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of corticosteroid, such as budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. The formulation is prepared by mixing SAE-CD, in solid or liquid (dissolved) form, with an inhalable suspension-based unit dose formulation. | 01-13-2011 |
20110123518 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid - An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution; however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. | 05-26-2011 |
20110224232 | Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation - A method of treating fungal infection by pulmonary administration of a solution of voriconazole and cyclodextrin is provided The fungal infection can be a pulmonary infection. The solution can be an inhalable aqueous formulation that can be administered via the mouth or nose. The cyclodextrin can be a water soluble cyclodextrin derivative such as sulfoalkyl ether cyclodextrin. The formulation can be administered via a spray device or nebulizer. | 09-15-2011 |
20110251157 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid - An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. | 10-13-2011 |
20130059826 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid - An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. | 03-07-2013 |
20130303498 | Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid - An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus. | 11-14-2013 |
Patent application number | Description | Published |
20100179541 | Wireless Electrosurgical Controller - The present disclosure relates to a wireless, bite activated switch for electrosurgery related electrosurgical systems, and methods of use thereof. During an electrosurgical procedure, a biocompatible switching device is gently held in the surgeon's mouth, typically between the teeth. The surgeon may activate an electrosurgical device by biting down on the switch. In embodiments, the wireless, bite activated switch includes a passive RFID tag that is powered by a radiofrequency signal transmitted by an interrogator included within an electrosurgical system unit. The wireless, bite activated may include a unique identifier which enable the electrosurgical system unit to respond only to a designated wireless device. | 07-15-2010 |
20100179542 | Method for Wireless Control of Electrosurgery - The present disclosure relates to a method for performing electrosurgery. The disclosed method includes providing a wireless, bite-activated switch configured for use within a surgeon's mouth. The disclosed switch includes an activator, a transponder, and an antenna. The switch communicates with an electrosurgical energy source, such as without limitation, an electrosurgical RF or microwave generator, to convey the state of the switch and activate the generator. The disclosed method provides providing the wireless switch with a unique identifier and associating the generator with the unique switch to ensure only the intended switch can control the electrosurgical generator. | 07-15-2010 |
Patent application number | Description | Published |
20100155292 | NAKED COLLATION PACKAGE - A naked collation package comprising a plurality of individual units laid end-to-end or side-by-side to form a unit row comprising at least one interface between a neighbouring pair of individual units in the unit row, the unit row being overwrapped with a sheet of polymeric film having a length and a width, the length of the sheet being sufficient to envelop the unit row with sufficient overlap between the ends of the sheet to provide an overlap region for providing a girth seal along at least part of the length of the unit row, the sheet being sealed to itself in that region to provide the girth seal, and the sheet being provided along its length, or part or parts of it, with a line of weakness positioned in substantial register with the interface. | 06-24-2010 |
20120318703 | NAKED COLLATION PACKAGE WITH TUBE FORM - A naked collation package comprising a plurality of individual units laid end-to-end or side-by-side to form a unit row comprising at least one interface between a neighbouring pair of individual units in the unit row, the unit row being overwrapped with a sheet of polymeric film having a length and a width, the length of the sheet being sufficient to envelop the unit row with sufficient overlap between the ends of the sheet to provide an overlap region for providing a girth seal along at least part of the length of the unit row, the sheet being sealed to itself in that region to provide the girth seal, and the sheet being provided along its length, or part or parts of it, with a line of weakness positioned in substantial register with the interface. | 12-20-2012 |